Open AccessLabel-free rapid identification of tumor cells and blood cells with silver film SERS substrate
Author(s) -
Y. J. Zhang,
Qiuyao Zeng,
L. F. Li,
Minni Qi,
Q. C. Qi,
S. X. Li,
JunFa Xu
Publication year - 2018
Publication title -
optics express
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.394
H-Index - 271
ISSN - 1094-4087
DOI - 10.1364/oe.26.033044
Subject(s) - circulating tumor cell , nucleic acid , cancer cell , surface enhanced raman spectroscopy , substrate (aquarium) , cancer , materials science , raman spectroscopy , raman scattering , microbiology and biotechnology , chemistry , biophysics , cancer research , pathology , biology , medicine , biochemistry , optics , metastasis , ecology , physics
The detection of circulating tumor cells (CTCs) from peripheral blood is considered as great significance for the diagnosis and prognosis of cancer patients. Raman spectroscopy is a highly sensitive optical detection technique that can provide fingerprint molecular identification information. In this paper, the silver film substrate surface-enhanced Raman scattering (SERS) was used to research several tumor cells, immortalized cells, clinical cancer cells isolated from cancer patient's tissue and blood cells. The results display that there is great difference for the nucleic acid characteristic peaks of those cells. The red blood cells have almost none nucleic acid characteristic peak and the SERS signals of white blood cells are only a slight increase. Except for immortalized cells and few tumor cells, the nucleic acid characteristic peaks of some tumor cells have huge enhancement. Nucleic acid characteristic peaks of clinical cancer cells also have greater enhancement. The discriminant model established by the intensity ratio of the nucleic acid characteristic peak 730 cm -1 to the substrate background peak 900 cm -1 shows that some tumor cells and clinical sample cells can be separated from white blood cells, but tumor cells with relatively low-DNA index cannot be differentiated from white blood cells. This study demonstrates that thin-film SERS technology can distinguish between blood cells and some types of tumor cells. This study opens up a new possible method for the detection of CTCs with label-free SERS spectra.